BOLT SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class Action

Posted on by

NEWTOWN, Pa., July 12, 2024 /PRNewswire/ — Edelson Lechtzin LLP, a leading class action law firm, reminds investors about the impending deadline to seek appointment as lead plaintiff in the securities fraud class action lawsuit against Bolt Biotherapeutics, Inc. (NASDAQ: BOLT). If you…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.